|
1
|
Large cell carcinoma of the lung: an endangered species?
|
Appl Immunohistochem Mol Morphol
|
2009
|
0.95
|
|
2
|
Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancer.
|
Cancer Res
|
2004
|
0.92
|
|
3
|
Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer.
|
BMC Genomics
|
2010
|
0.91
|
|
4
|
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.
|
J Natl Cancer Inst
|
2013
|
0.88
|
|
5
|
Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.84
|
|
6
|
Angiomyolipoma and PEComa are immunoreactive for MyoD1 in cell cytoplasmic staining pattern.
|
Appl Immunohistochem Mol Morphol
|
2003
|
0.83
|